Home Resources Webinars

Webinars

Combinatorial Immunotherapy Approaches for Patients with Advanced Solid Tumors

In this exciting new webinar, sponsored by Ultivue, we will explore the intratumoral administration of autologous, non-manipulated myeloid dendritic cells in combination with immune checkpoint inhibitors in patients with advanced solid tumors and in combination with the oncolytic virus talimogene laherparepvec (Imlygic®) in patients with advanced melanoma in phase I clinical trials.

AAV Based Gene Therapy for Rare Genetic Disorders: Strategies and Challenges

In this GEN webinar, sponsored by WuXi AppTec, we will review the challenges of utilizing AAV, as well as discuss in detail the recent progress and outstanding questions in AAV-based gene therapy.

Accelerating Vaccine Development through Use of Blood-Free Components

This GEN webinar, sponsored by Invitria, will discuss the real contamination risks described in a recent study and how companies are rising to this challenge through a better selection of components and excipients.

Scalable AAV Manufacturing: Addressing Challenges Across the Workflow

In this GEN webinar, sponsored by Thermo Fisher Scientific, our presenters will highlight upstream and downstream solutions across the AAV production workflows.

High-Throughput Proteomics During a Pandemic

In this GEN webinar, sponsored by Bruker, our esteemed presenter Dr. Roman Fischer from the University of Oxford, will showcase the application andlimitations of high-throughput timsTOF Pro mass spectrometry on large scale clinicalsample sets in order to stratify patients and contribute to a multi-omics blood atlasof COVID-19 patients, and the combination of laser capture microdissection withproteomics methods for the 3D characterization of large biological macrostructuressuch as organs or tumors.

The Secret to Improving the Therapeutic Index of Antibody Drug Conjugates

REGISTER NOW Broadcast Date: February 5, 2019 Time: 8:00 am PT, 11:00 am ET, 17:00 CET Antibody-drug conjugates (ADCs) were initially developed to provide a selective targeting...

Preventing Dementia through a Virtual Twin Brain

GEN's on demand webinar, sponsored by Dassault Systèmes, discusses the current state of The Living Brain Project and how it is being applied to traumatic brain injury, neuromodulation, neurodegenerative disease progression, and drug delivery through cerebrospinal fluid.

Streamlined Formulation of Enzyme Products

REGISTER NOW Broadcast Date: February 26, 2019 Time: 8:00 am PT, 11:00 am ET, 17:00 CET There are two complementary paths to creating a stable enzyme formulation....

How to Decrease Long Read Sequencing Sample QC Time by 10-Fold

This presentation will show how low concentrated samples, as well as libraries prepared for long read sequencing benefit from QC, performed with the Femto Pulse.

Association Rate Constant: The Unsung Hero of Drug Discovery Kinetics

While the importance of ligand-receptor binding kinetics on drug action is becoming well established, focus to date has been almost entirely on the role of the dissociation constant on drug efficacy and duration of action. The association rate constant, in contrast, has been largely overlooked, with many investigators still considering it diffusion-limited and equivalent across a compound series. This GEN webinar aims to remedy that by turning the spotlight onto the undervalued and oft-ignored association rate constant.

Recent Advances and the Future of Antibody Engineering

In this GEN webinar, we will hear from Danica Stanimirovic MD, PhD, and Danica Stanimirovic MD, PhD, wto leading scientists who will describe their current antibody engineering research projects and the therapeutic potential they hold.

Pancreatic Cancer Therapeutic Target Visualized Using In Situ Hybridization

In this GEN webinar sponsored by Advanced Cell Diagnostics, we will hear about new PDAC research showing that the cytokine leukemia inhibitory factor (LIF) key paracrine factor from activated pancreatic stellate cells acting on cancer cells.

Measuring Multivalent Interactions: Uncovering the Secrets of Virus Binding Strategies

In this GEN webinar, we will learn from Dr. Daniel Lauster, who, when faced with many of the challenges described above, utilized MicroScale Thermophoresis (MST) to measure the interaction between more than 100 novel non-toxic multivalent nanoparticle-conjugates and intact IAV in solution with as little as nanomoles of nanoparticles. Additionally, we will hear from Dr. Matthias Molnar how MST is becoming scientists’ first choice for the characterization of molecular interactions thanks to its flexible throughput, low sample consumption, and measurements in solution or in close to native conditions.

Mind the Yap! Single-Cell Transcriptomes Reveal Drivers of Intestinal Regeneration

In this GEN webinar, we will hear about recent findings implicating the Hippo effector, Yap, as a driver of a novel damaged-induced intestinal stem cell population.

Managing Multiple Biomarker Therapeutic Development

In this roundtable, our panelists will discuss assessing the validity of biomarkers to inform drug development and potential combination therapies. Key considerations include predictive testing of biomarkers, analytical methods, drug-diagnostic co-development and potential reimbursement considerations.

Recently Featured

Scroll Up